Although improvements were seen in the NSE/NSEB groups in this study and NSE seems to be cost-effective compared to NSEB and PPA in chronic WAD [30], caution is warranted when comparing with other groups of patients. Here, ENO2 is linked to acrofacial dysostosis, Weyers type.